How API Pharma Companies Are Reshaping Global Drug Supply Chains in 2026
API pharma companies sit at the center of today’s drug supply chain, yet their impact is often felt only when something goes wrong. Delays in API availability, quality deviations, or regulatory findings can quickly cascade into missed timelines, budget overruns, and stalled programs. For executives, these risks translate into pressure from regulators, investors, and partners, […]